Nigeria - 2016 - Health

NAFDAC Good Manufacturing Practice Guidelines for Pharmaceutical Products 2016

Ministry of Industry, Trade and Investment, National Agency for Food and Drug Administration and Control, Nigeria

Good manufacturing practice (GMP) is that part of quality assurance which ensures that pharmaceutical products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by their marketing authorizations. These guidelines apply to pharmaceutical, biological, and veterinary products and they are intended to help all stakeholders comply with the provisions of the National Agency for Food and Drug Administration and Control (NAFDAC) good manufacturing Practice Regulations for pharmaceutical products.

Process Flow

Department of Pharmacovigilance and Post Marketing Surveillance ⬤

Office of the Director General NAFDAC ⬤

Office of the Permanent Secretary, Ministry of Health ⬤

Office of the Minister of State for Health ⬤

Office of the Minister of Health ⬤

Federal Executive Council ⬤

Contacts

Approver

Fraden Bitrus

Deputy Director i/c

National Agency for Food and Drug Administration and Control (NAFDAC)

Approver

Moji Adeyeye

Director General

National Agency for Food and Drug Administration and Control (NAFDAC)

Approver

Mahmuda Mamman

Permanent Secretary

Ministry of Health

Approver

Adeleke O. Mamora

Honourable Minister of State

Ministry of Health

Approver

Osagie Ehanire

Honourable Minister

Ministry of Health

Approver

Muhammadu Buhari

President of the Federal Republic of Nigeria

Compare Versions Please select two versions

NAFDAC Good Manufacturing Practice Guidelines for Pharmaceutical Products 2016 Current Version

January 2022

Good manufacturing practice (GMP) is that part of quality assurance which ensures that pharmaceutical products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by their marketing authorizations. These guidelines apply to pharmaceutical, biological, and veterinary products and they are intended to help all stakeholders comply with the provisions of the National Agency for Food and Drug Administration and Control (NAFDAC) good manufacturing Practice Regulations for pharmaceutical products.

Request Expert Analysis

Ask one of our policy analysts to take an in-depth look at this policy and provide you with a written summary. An additional cost may apply. Please let us know what questions you are looking to answer.

Thank you for requesting an expert analysis

A member of our team will review your request and reply back to the email address on file.